MX2009012179A - Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma. - Google Patents
Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma.Info
- Publication number
- MX2009012179A MX2009012179A MX2009012179A MX2009012179A MX2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A MX 2009012179 A MX2009012179 A MX 2009012179A
- Authority
- MX
- Mexico
- Prior art keywords
- melanoma
- treatment
- pharmaceutically acceptable
- acceptable salt
- hdac inhibitor
- Prior art date
Links
- 239000003276 histone deacetylase inhibitor Substances 0.000 title abstract 4
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 229940121372 histone deacetylase inhibitor Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención se refiere al uso de un inhibidor de desacetilasa de histona, más específicamente a una sal farmacéuticamente aceptable del mismo, para la fabricación de composiciones farmacéuticas para el tratamiento de melanoma; al uso de un inhibidor de desacetilasa de histona o una sal farmacéuticamente aceptable del mismo, en el tratamiento de melanoma; a un método para el tratamiento de animales de sangre caliente, incluyendo mamíferos, en especial seres humanos, que sufran de melanoma, mediante la administración a este animal que necesite dicho tratamiento, de una dosis efectiva contra la enfermedad mencionada, de un inhibidor de desacetilasa de histona o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91734507P | 2007-05-11 | 2007-05-11 | |
| US93827207P | 2007-05-16 | 2007-05-16 | |
| PCT/US2008/063136 WO2008141114A1 (en) | 2007-05-11 | 2008-05-09 | Use of hdac inhibitors for the treatment of melanoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009012179A true MX2009012179A (es) | 2009-12-01 |
Family
ID=39641895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012179A MX2009012179A (es) | 2007-05-11 | 2008-05-09 | Uso de inhibidores de desacetilasa de histona (hdac) para el tratamiento de melanoma. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20110034531A1 (es) |
| EP (1) | EP2155193A1 (es) |
| JP (1) | JP2010526830A (es) |
| KR (1) | KR20100016376A (es) |
| CN (1) | CN101677995A (es) |
| AU (1) | AU2008251499A1 (es) |
| CA (1) | CA2684114A1 (es) |
| CL (1) | CL2008001363A1 (es) |
| IL (1) | IL201439A0 (es) |
| MA (1) | MA31365B1 (es) |
| MX (1) | MX2009012179A (es) |
| RU (1) | RU2009145803A (es) |
| TN (1) | TN2009000449A1 (es) |
| TW (1) | TW200911231A (es) |
| WO (1) | WO2008141114A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
-
2008
- 2008-05-09 JP JP2010507680A patent/JP2010526830A/ja not_active Withdrawn
- 2008-05-09 CL CL2008001363A patent/CL2008001363A1/es unknown
- 2008-05-09 KR KR1020097023399A patent/KR20100016376A/ko not_active Withdrawn
- 2008-05-09 CA CA002684114A patent/CA2684114A1/en not_active Abandoned
- 2008-05-09 MX MX2009012179A patent/MX2009012179A/es not_active Application Discontinuation
- 2008-05-09 EP EP08747872A patent/EP2155193A1/en not_active Withdrawn
- 2008-05-09 US US12/594,978 patent/US20110034531A1/en not_active Abandoned
- 2008-05-09 AU AU2008251499A patent/AU2008251499A1/en not_active Abandoned
- 2008-05-09 CN CN200880015739A patent/CN101677995A/zh active Pending
- 2008-05-09 WO PCT/US2008/063136 patent/WO2008141114A1/en not_active Ceased
- 2008-05-09 TW TW097117331A patent/TW200911231A/zh unknown
- 2008-05-09 RU RU2009145803/15A patent/RU2009145803A/ru not_active Application Discontinuation
-
2009
- 2009-10-11 IL IL201439A patent/IL201439A0/en unknown
- 2009-10-29 TN TNP2009000449A patent/TN2009000449A1/fr unknown
- 2009-11-09 MA MA32330A patent/MA31365B1/fr unknown
-
2011
- 2011-07-26 US US13/190,764 patent/US20110288144A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008251499A1 (en) | 2008-11-20 |
| US20110288144A1 (en) | 2011-11-24 |
| WO2008141114A1 (en) | 2008-11-20 |
| US20110034531A1 (en) | 2011-02-10 |
| MA31365B1 (fr) | 2010-05-03 |
| CA2684114A1 (en) | 2008-11-20 |
| KR20100016376A (ko) | 2010-02-12 |
| CN101677995A (zh) | 2010-03-24 |
| CL2008001363A1 (es) | 2008-12-19 |
| JP2010526830A (ja) | 2010-08-05 |
| EP2155193A1 (en) | 2010-02-24 |
| TN2009000449A1 (en) | 2011-03-31 |
| TW200911231A (en) | 2009-03-16 |
| RU2009145803A (ru) | 2011-06-20 |
| IL201439A0 (en) | 2010-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
| EA201070328A1 (ru) | Соединения триазолопиридина и их применение в качестве ингибиторов ask | |
| MX368368B (es) | Compuestos de indol e indazol como un inhibidor de necrosis celular. | |
| EA201690033A2 (ru) | Морфинановые соединения | |
| EA201101507A1 (ru) | Способы лечения солидных опухолей | |
| MY162157A (en) | Substituted indole mcl-1 inhibitors | |
| EA201290919A1 (ru) | Индазольные соединения и их применение | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| UA100116C2 (ru) | Профилактика или лечение воспалительного заболевания | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| EA201290191A1 (ru) | N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ | |
| TW200744586A (en) | Therapeutic compounds | |
| MX346186B (es) | Inhibidores de proteina cinasas. | |
| EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| EA201290859A1 (ru) | Лечение люпус-артрита с использованием лаквинимода | |
| MX2014007969A (es) | Hidroxiamidas de ácido cinámico como inhibidores de la histona desacetilasa 8. | |
| MX2009005649A (es) | Tratamiento para mieloma multiple. | |
| EA201390428A1 (ru) | Композиции и способы лечения легочной гипертензии | |
| EA201490552A1 (ru) | Холиновая соль замещенного циклобутендиона, обладающая противовоспалительной способностью | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| GT200600160A (es) | Tratamiento del dolor | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| MX2013002649A (es) | Agente terapeutico contra el dolor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FA | Abandonment or withdrawal |